Navigation Links
$10 Million Gift to Transform Neuromedicine at URMC
Date:5/13/2009

ROCHESTER, N.Y., May 13 /PRNewswire-USNewswire/ -- A multi-million dollar gift from one of Rochester's hometown entrepreneurs promises to launch the University of Rochester Medical Center's (URMC) neuromedicine program into a nationally recognized, comprehensive center for investigating and treating neurological conditions such as Alzheimer's disease, Parkinson's disease, muscular dystrophy, stroke, and trauma to the brain and spinal cord.

Ernest J. Del Monte, chairman of E.J. Del Monte Corporation, a Rochester-based company that owns and operates 17 hotels in New York State, chose to make the gift with his wife, Thelma, after getting to know neuromedicine leaders at the Medical Center. He's impressed that scientific studies in Rochester are providing critical insight into neurological diseases such as Alzheimer's, stroke, brain tumors and injuries to the brain and spinal cord, all of which are rapidly becoming more prevalent. At a URMC news conference today, Del Monte said that his family's $10 million gift is the first installment toward what he hopes will amount to a $20 million commitment to the Institute over time. At $10 million, the Del Monte contribution is the second largest gift in the history of the Medical Center.

"Neuromedicine is one of the most promising endeavors that the University has undertaken," Del Monte said. "We have all the necessary ingredients to be successful internationally. My hope is that this gift will be the force to help scientists and clinicians collaborate seamlessly so that one day, from this Institute, the cure for Alzheimer's disease, stroke and other neurological disorders will emerge. I truly believe we can do it."

"The University of Rochester is deeply indebted to Mr. Del Monte for his extraordinary generosity," said University President Joel Seligman. "Ernie and Thelma's gift is potentially trans
'/>"/>

SOURCE University of Rochester Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
3. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
4. 1.5 million children could be saved
5. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
6. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
9. £5 million investment in personalized medicines to cut patient deaths
10. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2Gentiva 28R 29 Health Services to Present at Jefferies 3rd Annual Healthcare Conference 48155 1Gentiva 28R 29 Health Services to Present at Jefferies 3rd Annual Healthcare Conference 48155 2Gentiva 28R 29 Health Services to Present at Jefferies 3rd Annual Healthcare Conference 48155 3PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately 24125 Million 12517 1PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately 24125 Million 12517 2PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately 24125 Million 12517 3Pasteuria Bioscience Receives EPA Registration for Nematode Control 12514 1Pasteuria Bioscience Receives EPA Registration for Nematode Control 12514 2